Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer

N. Takigawa, K. Kiura, Y. Segawa, Y. Watanabe, H. Kamei, T. Moritaka, T. Shibayama, H. Ueoka, K. Gemba, T. Yonei, M. Tabata, T. Shinkai, S. Hiraki, M. Takemoto, S. Kanazawa, K. Matsuo, M. Tanimoto

研究成果査読

25 被引用数 (Scopus)

抄録

Long-term cancer survivors risk development of second primary cancers (SPC). Vigilant follow-up may be required. We report outcomes of 92 patients who underwent chemoradiation for unresectable stage III non-small-cell lung cancer, with a median follow-up of 8.9 years. The incidence of SPC was 2.4 per 100 patient-years (95% confidence interval: 1.0-4.9).

本文言語English
ページ(範囲)1142-1144
ページ数3
ジャーナルBritish Journal of Cancer
95
9
DOI
出版ステータスPublished - 11月 6 2006

ASJC Scopus subject areas

  • 腫瘍学
  • 癌研究

フィンガープリント

「Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル